Ninlib (Nilotinib 200 mg) Capsules In Pakistan

Ninlib 200 mg Capsules contain nilotinib, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It is used in the treatment of certain types of blood cancer, particularly Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML), under the supervision of a qualified hematologist or oncologist.

Nilotinib works by blocking the abnormal BCR-ABL tyrosine kinase protein responsible for the uncontrolled growth of leukemia cells.

Product Information

Uses of Ninlib 200 mg

Nilotinib may be prescribed for:

• Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia (Ph+ CML).

• Certain cases of CML when previous treatment, such as imatinib, has not worked or has caused unacceptable side effects.

• Other approved CML indications, depending on the patient's age and clinical condition.

How to Take Ninlib Capsules

• Take only according to your oncologist's prescription.

• Nilotinib is generally taken on an empty stomach, at least 2 hours after food and 1 hour before the next meal.

• Swallow capsules as directed by your healthcare professional.

• Do not change the dose or stop treatment without medical advice.

Possible Side Effects

Potential side effects include:

• Headache and nausea

• Abdominal discomfort

• Rash and itching

• Changes in blood cell counts

• Changes in liver function, blood sugar, or cholesterol levels

Nilotinib can also cause serious heart rhythm problems, so ECGs and regular laboratory monitoring are important.

Precautions and Warnings

Inform your doctor about all medicines and supplements you use, particularly medicines that may affect heart rhythm or interact with nilotinib. Patients may require regular blood tests, electrolyte checks, and heart monitoring.

Prescription medicine: Ninlib 200 mg should be used under specialist supervision. It is not suitable for self-medication.